Volumetric Intravascular Ultrasound Assessment of Neointimal Hyperplasia and Nonuniform Stent Strut Distribution in Sirolimus-Eluting Stent Restenosis

American Journal of Cardiology

Volumn 98, Issue 12, 2006, Pages 1559-1562

  Sano, Koichi ^a   Mintz, Gary S ^a   Carlier, Stéphane G ^a   Fujii, Kenichi ^a   Takebayashi, Hideo ^a   Kimura, Masashi ^a   Costa Jr , Jose Ribamar ^a   Tanaka, Kaoru ^a   Costa, Ricardo A ^a   Lui, Joanna ^a   Weisz, Giora ^a   Moussa, Issam ^a   Dangas, George D ^a   Mehran, Roxana ^a   Lansky, Alexandra J ^a   Kreps, Edward M ^a   Collins, Michael ^a   Stone, Gregg W ^a   Moses, Jeffrey W ^a   Leon, Martin B ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG ELUTING STENT; FEMALE; HUMAN; IMPLANTATION; INTRAVASCULAR ULTRASOUND; MALE; PRIORITY JOURNAL; RESTENOSIS;

AGED; CORONARY RESTENOSIS; CORONARY VESSELS; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERPLASIA; MALE; SIROLIMUS; STENTS; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 34347360228     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.07.030     Document Type: Article

References (18)

1. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
2. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
3. Schofer J., Schluter M., Gershlick A.H., Wijns W., Garcia E., Schampaert E., and Breithardt G. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
4. Takebayashi H., Mintz G.S., Carlier S.G., Kobayashi Y., Fujii K., Yasuda T., Costa R.A., Moussa I., Dangas G.D., Mehran R., et al. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 110 (2004) 3430-3434
5. Takebayashi H., Kobayashi Y., Mintz G.S., Carlier S.G., Fujii K., Yasuda T., Moussa I., Mehran R., Dangas G.D., Collins M.B., et al. Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation. Am J Cardiol 95 (2005) 498-502
6. Lemos P.A., Hoye A., Goedhart D., Arampatzis C.A., Saia F., van der Giessen W.J., McFadden E., Sianos G., Smits P.C., Hofma S.H., et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 109 (2004) 1366-1370
7. Sianos G., Hofma S., Ligthart J.M., Saia F., Hoye A., Lemos P.A., and Serruys P.W. Stent fracture and restenosis in the drug-eluting stent era. Catheter Cardiovasc Interv 61 (2004) 111-116
8. Mintz G.S., Nissen S.E., Anderson W.D., Bailey S.R., Erbel R., Fitzgerald P.J., Pinto F.J., Rosenfield K., Siegel R.J., Tuzcu E.M., and Yock P.G. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 37 (2001) 1478-1492
9. Halkin A., Carlier S., and Leon M.B. Late incomplete lesion coverage following Cypher stent deployment for diffuse right coronary artery stenosis. Heart 90 suppl (2004) e45
10. Sonoda S., Morino Y., Ako J., Terashima M., Hassan A.H., Bonneau H.N., Leon M.B., Moses J.W., Yock P.G., Honda Y., et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the Sirius trial. J Am Coll Cardiol 43 (2004) 1959-1963
11. Cheneau E., Pichard A.D., Satler L.F., Suddath W.O., Weissman N.J., and Waksman R. Intravascular ultrasound stent area of sirolimus-eluting stents and its impact on late outcome. Am J Cardiol 95 (2005) 1240-1242
12. Weissman N.J., Koglin J., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., et al. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1201-1205
13. Balakrishnan B., Tzafriri A.R., Seifert P., Groothuis A., Rogers C., and Edelman E.R. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents. Circulation 111 (2005) 2958-2965
14. Sabate M., Jimenez-Quevedo P., Angiolillo D.J., Gomez-Hospital J.A., Alfonso F., Hernandez-Antolin R., Goicolea J., Banuelos C., Escaned J., Moreno R., et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the Diabetes and Sirolimus-Eluting Stent (DIABETES) trial. Circulation 112 (2005) 2175-2183
15. Ortolani P., Ardissino D., Cavallini C., Bramucci E., Indolfi C., Aquilina M., and Marzocchi A. Effect of sirolimus-eluting stent in diabetic patients with small coronary arteries (a SES-SMART substudy). Am J Cardiol 96 (2005) 1393-1398
16. Moussa I., Leon M.B., Baim D.S., O'Neill W.W., Popma J.J., Buchbinder M., Midwall J., Simonton C.A., Keim E., Wang P., et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 109 (2004) 2273-2278
17. Kuchulakanti P.K., Torguson R., Canos D., Rha S.W., Chu W.W., Clavijo L., Deible R., Gevorkian N., Suddath W.O., Satler L.F., et al. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients. Am J Cardiol 96 (2005) 1100-1106
18. Yang T.H., Park S.W., Hong M.K., Park D.W., Park K.M., Kim Y.H., Han K.H., Lee C.W., Cheong S.S., Kim J.J., and Park S.J. Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era. Am J Cardiol 96 (2005) 1389-1392